Conagra Brands (CAG US)
CAG US$13.92
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 13.92
- Change
- ▼ -0.32 (-2.25)
- Bid / Ask
- 13.92 - 13.93
- Volume
- 2,061,980
- Turnover
- 27,829,767
- Open
- 14.06
- Day Range
- 13.81 - 14.14
- VWAP
- 13.93
- Prev Close
- 14.24
- Last Trade
- 28/10 4:10pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Consumer Defensive
- Shares Issued
- 477,411,517
- NTA/Share
- -7.51
- Last Dividend
- 0.18
- Dividend Ex Date
- 30 JUL 2026
- Dividend Pay Date
- 2 SEP 2026
Current (USD) · FY2026
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 11,281.60
- EBITDA
- -1,045.80
- Profit
- -1,916.20
- Earnings Per Share (EPS)
- -4.00
- Dividend Per Share (DPS)
- 1.40
- Yield %
- 8.13
- Market Cap
- 6,645.57
- Price to Earnings Ratio (P/E)
- -3.50
Estimates (USD) · FY2027
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- 10,816.90
- EBITDA
- —
- Profit
- 703.50
- Earnings Per Share (EPS)
- 1.45
- Dividend Per Share (DPS)
- —
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Undervalued
- Economic Moat
- None
- Financial Health
- Moderate
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 22 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 17.54 Fair value 19.74 One-star price 22.21
Morningstar Quantitative Rating as of 22 OCT 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 19.74
- Price / Fair Value
- 0.76
- Valuation
- Undervalued
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 22 OCT 2026. The slider runs from the five-star price (17.54) to the one-star price (22.21).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): USD/USD |
| Exchange Rate: 1.0000 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 15.07 |
| Price - 12 month high | 20.32 |
| Price - 12 month low | 12.53 |
| Pricing date | 21 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 10.44 |
| Market capitalization | 7,194.59 |
| 12 Month High price date | 12 FEB 2026 |
| 12 Month Low price date | 4 JUN 2026 |
| Volume - avg. trading volume for the last 3 months | 12.17 |
| Price - 1 Day % Change | 7.34% |
| Price - 13 week price percent change | 1.62% |
| Price - 26 week price percent change | 3.72% |
| Price - 5 Day % Change | 6.28% |
| Price - 52 week price percent change | -19.76% |
| Price - YTD price percent change | -13.54% |
| Price % Change Month To Date | 1.96% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | -4.000 |
| EPS excluding extraordinary items - trailing 12 month | -3.980 |
| EPS Normalized - most recent fiscal year | 1.720 |
| Revenue/share - most recent fiscal year | 23.552 |
| Revenue/share - trailing 12 month | 23.468 |
| Book value per share - most recent fiscal year | 13.285 |
| Book value per share - most recent quarter | 13.416 |
| Book value (tangible) per share - most recent fiscal year | -7.507 |
| Book value (tangible) per share - most recent quarter | -7.402 |
| Cash per share - most recent fiscal year | 0.456 |
| Cash per share - most recent quarter | 0.778 |
| Cash Flow per share - most recent fiscal year | 2.901 |
| Cash Flow per share - trailing 12 month | 2.949 |
| Dividend per share - most recent fiscal year | 1.400 |
| Dividends per share - trailing 12 month | 1.225 |
| EBITD per share - trailing 12 month | -2.299 |
| EPS Basic excluding extraordinary items - most recent fiscal year | -4.000 |
| EPS Basic excluding extraordinary items - trailing 12 month | -3.980 |
| EPS including extraordinary items - most recent fiscal year | -4.000 |
| EPS including extraordinary items - trailing 12 month | -3.980 |
| Free Cash Flow per share - trailing 12 month | 2.113 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | — |
| P/E Normalized, most recent fiscal year | 8.76 |
| Price to sales - most recent fiscal year | 0.64 |
| Price to Tangible Book - most fiscal year | — |
| Price to Free Cash Flow per Share - most recent fiscal year | 7.13 |
| Price to Cash Flow per share - trailing 12 month | 5.11 |
| Price to Book - most recent fiscal year | 1.12 |
| P/E excluding extraordinary items high, trailing 12 months | 10.51 |
| P/E excluding extraordinary items low, trailing 12 months | 9.49 |
| Net Debt, LFI | 7,388.50 |
| Net Debt, LFY | 7,050.40 |
| Dividend Yield - 5 Year Average | 4.82% |
| Dividend Yield - indicated annual dividend divided by closing price | 8.73% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 8.13% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | 966.10 |
| LT debt/equity - most recent fiscal year | 101.55% |
| Payout ratio - most recent fiscal year | -35.00% |
| Total debt/total equity - most recent fiscal year | 114.33% |
| LT debt/equity - most recent quarter | 108.36% |
| Total debt/total equity - most recent quarter | 121.16% |
| Free Cash Flow - trailing 12 month | 1,012.50 |
| Payout ratio - trailing 12 month | -48.37% |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 11,281.60 |
| Revenue - trailing 12 month | 11,244.90 |
| EBITD - most recent fiscal year | -1,045.80 |
| EBITD - trailing 12 month | -1,101.40 |
| Earnings before taxes - most recent fiscal year | -1,824.40 |
| Earnings before taxes - trailing 12 month | -1,880.60 |
| Net Income available to common - most recent fiscal year | -1,916.20 |
| Net Income available to common - trailing 12 months | -1,906.40 |
| Earnings before taxes Normalized - most recent fiscal year | 4,068.60 |
| Net Income Available to Common, Normalized - most recent fiscal year | 823.30 |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 1.72 |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | -16.99% |
| Net Profit Margin % - trailing 12 month | -16.95% |
| Operating margin - 1st historical fiscal year | 11.16% |
| Operating margin - trailing 12 month | 10.87% |
| Pretax margin - trailing 12 month | -16.72% |
| Pretax margin - 1st historical fiscal year | -16.17% |
| Operating Margin - 5 year average | 13.14% |
| Pretax Margin - 5 year average | 3.28% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 9.35% |
| Free Operating Cash Flow/Revenue, TTM | 9.00% |
| Net Profit Margin - 5 year average | 1.82% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | -9.76% |
| Return on average assets - trailing 12 month | -10.04% |
| Return on average equity - most recent fiscal year | -23.68% |
| Return on average equity - trailing 12 month | -25.13% |
| Return on average assets - 5 year average | 1.81% |
| Return on average equity - 5 year average | 4.62% |
| Net Income/employee - most recent fiscal year | -110,126.44 |
| Revenue/employee - most recent fiscal year | 648,367.82 |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | 0.17% |
| EPS growth rate, 5 year | — |
| Growth rate% - dividend, 3 year | 1.98% |
| Revenue/share (5 yr growth) | 0.54% |
| Growth rate% - Revenue, 3 year | -2.78% |
| Growth rate% - EPS, 3 year | — |
| Book value per share growth rate, 5 year | -5.69% |
| Capital Spending growth rate, 5 year | -3.52% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | — |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (USD, millions except per share)
| Actuals | Estimates | |||||||
| 2026 | 2027 | 2028 | ||||||
| Estimate breakdown | ||||||||
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (USD, millions)
| Period end: | MAY 22 | MAY 23 | MAY 24 | MAY 25 | MAY 26 |
| Fiscal year: | 2022 | 2023 | 2024 | 2025 | 2026 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.
Business Summary
Conagra Brands Inc is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). The majority of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company sells through the USA retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
